(Q43564749)

English

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence Universit

scientific article published in April 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence Universit (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Stefano Maria Magrini

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Giovanna Masala

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Adele Seniori Costantini

5

object named as

Costantini AS

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Cellai E

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Alterini R

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rigacci L

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Olmastroni L

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Papi MG

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Spediacci MA

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Innocenti F

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bellesi G

11

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ferrini PR

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Biti G

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1327-1337

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Late effects of treatment for early-stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancies and Hodgkin's disease--the Royal Marsden Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease: study of treatment intensities and incidences of second malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Late complications after Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease: is there a price for successful treatment? A 25-year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer following Hodgkin's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease: subsequent primary cancers in relation to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901513-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01513-3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43564749&oldid=2101128247"